FocusCancer

The Fringe Benefits of Cloning Cancer

Science Translational Medicine  17 Sep 2014:
Vol. 6, Issue 254, pp. 254fs36
DOI: 10.1126/scitranslmed.3010174

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

A new approach to monitoring tumor clone dynamics (Carreira et al., this issue) uses sequential biopsies and circulating DNA to help optimize treatment in metastatic prostate cancer.

View Full Text